[December 05, 2012]

Clinical Research Advantage Receives Gold Best in Biz Award for Business Development Department of the Year

Clinical Research Advantage (CRA) received top honors in this year's Best in Biz Awards, the only independent business awards program judged by members of the press and industry analysts. CRA received the Gold Award for Business Development Department of the Year.

Casey Orvin, Vice President of Business Development, and Amanda Drake, Director of Business Development, were recognized for their achievements in helping the company grow to become the largest and most therapeutically diverse integrated site network in the clinical trials industry.

"Casey Orvin and Amanda Drake have been vital to CRA's substantial growth over the past couple of years," said Mark S. Hanley, the company's Chief Executive Officer. "Through their efforts, the number of clinical trials conducted y CRA increased by nearly 150%, and it continues to grow at an unprecedented rate."

More than 400 entries were received in this year's awards program, from a wide array of public and private companies of all sizes and from a variety of industries and regions in the U.S. and Canada.

Winners of Best in Biz Awards 2012 were determined by an independent panel of 32 judges from top-tier news, business and technology publications, as well as broadcast outlets and analyst firms, such as ABC, Businessweek, Computerworld, ECT News Network, Entrepreneur, eWeek, Examiner, Financial Times (News - Alert), Forbes, FOX News, Hartford Business Journal, IDG Ventures, IEEE Institute, Inc., Insight Media, King Features Syndicate, Lab Reviews, Network World, The News and Observer, PC Magazine, ReadWriteWeb, South Florida Business Journal, Tech-Gaming, Techtalk, Upstart Business Journal, USA Today and ZDNet.

About Clinical Research Advantage

Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations. As a leading trial management organization, CRA operates from 38 sites across 17 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and efficiently. Founded in 1992, CRA has successfully completed more than 1,800 clinical trials on behalf of its clients. For more information, please visit www.crastudies.com.

[ Back To TMCnet.com's Homepage ]